Skip to main content
. 2022 Apr 8;2022:9129984. doi: 10.1155/2022/9129984

Figure 3.

Figure 3

AT III inhibits DSS-induced intestinal barrier impairment. (a, b) Western blots for occludin and ZO-1 proteins and quantification results. (c, d) Representative immunofluorescent images for occludin and quantification results. (e, f) Representative immunofluorescent images for ZO-1 and quantification results. Scale bar: 50 μm.